Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

AMR: EU ban on group use of prophylactics confirmed
Georgina Crayford, NPA’s senior policy advisor, said the changes could have major implications for the way pig health is managed.

NPA says there could be major implications for pig health

An EU ban on the prophylactic use of antibiotics in groups of animals has been confirmed.

Under the revised EU Regulation on Veterinary Medicinal Products, which comes into force in 2021, veterinary surgeons will only be able to prescribe prophylactic antibiotics for administration to individual animals.

The regulation states: ‘Antimicrobial medicinal products shall not be used for prophylaxis unless, in exceptional cases for the administration to an individual animal or a restricted number of animals when the risk of an infection or of an infectious disease is very high and the consequences are likely to be severe.

‘In such cases the use of antibiotic medicinal products for prophylaxis shall be limited to the administration to individual animal only, under the conditions laid down in the first sentence.’

In a recent letter to the UK’s chief veterinary officer, the National Pig Association and Pig Veterinary Society raised serious concerns about the plans.

Whilst agreeing that prophylaxis should only be deployed in ‘exceptional cases’, the two organisations warned that limiting this to individual animals is ‘unnecessary and risks seriously impacting pig health’.

Georgina Crayford, NPA’s senior policy advisor, said the changes could have major implications for the way pig health is managed.

“The NPA is working with RUMA, PVS and others to fully understand how this piece of legislation will be interpreted and what the implications will be for disease management in pigs,” she explained.

“We fully agree, of course, that prophylaxis should not be deployed routinely and only in exceptional circumstances. But we see no logic in prohibiting its use in groups of pigs, when it is deemed necessary for pigs’ health.”

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.